IRVINE, CA / ACCESSWIRE / February 9, 2021 / Odyssey Team Global, Inc. (OTCQB: ODYY ) (the “Company” or “Odyssey”), a engineering and asset acquisition organization concentrated on producing distinctive, life-preserving medical items, is delighted to announce multiple recent tv segments focused on the advancement of a remedy for concussion by Prevacus’, CEO Dr. Jake VanLandingham and Brett Favre. The appearances involved:
- CheddarTV’s “Closing Bell” on Friday, February 5 ( check out on-line )
- Newsmax’s “National Report” on Sunday, February 7 ( look at on the net ) and
- Fox Business’ “Kennedy Nation” on Monday February 8 ( view on line )
In addition, former NFL stars Kurt Warner and Mark Rypien mentioned brain injuries and the Prevacus drug prospect on Fox News’ “Fox and Friends” on Saturday February 6 ( view on the web ).
“We are thrilled with the beneficial consideration from the media that Prevasol, our pre-clinical phase concussion cure, is acquiring, and are thrilled about our pending partnership with Odyssey.” explained Dr. Jake VanLandingham, Chief Government Officer of Prevacus.
Michael Redmond, CEO of Odyssey extra “Concussion is a critical well being challenge in sporting activities, the navy and in elderly populations which at present has no Fda authorized drug cure. We are keen to near our transaction and be a section of the drug enhancement software.”
Odyssey previously entered into a definitive agreement with Prevacus to get the Active Pharmaceutical Ingredient PRV-002 (Prevasol) to take care of traumatic brain harm, on January 11, 2021. The definitive arrangement has been signed and the transaction is expected to near by the stop of February 2021, the transaction is conditional on Prevacus shareholder approval and other customary closing problems.
About Odyssey Group Intercontinental, Inc.
Odyssey Group International, Inc. (OTCQB: ODYY ) is a technological know-how and asset acquisition enterprise with a target in the region of life saving health-related remedies. Odyssey’s company mission is to generate, obtain and accumulate distinctive belongings, mental properties, and excellent systems that present significant professional medical options. The Business is targeted on constructing and attaining assets in parts that have an discovered technological benefit, supply remarkable clinical utility, have a sizeable market option and offer stable returns to its valued shareholders and partners.
For more data, go to: http://www.odysseygi.com
About Prevacus, Inc.
Prevacus, Inc. is a biopharmaceutical firm building drug candidates with the prospective to progress treatment in the fields of traumatic mind damage and other neurological issues. The Company’s to start with two development candidates (PRV-002 and PreVPro) stand for breakthrough method for treating concussion functioning at the molecular degree to at the same time reduce swelling, inflammation, impaired cerebral blood flow and oxidative anxiety.
For much more information take a look at: http://www.prevacus.com.
This news launch could incorporate ahead-on the lookout statements inside of the that means of the “safe harbor” provisions of the Personal Securities Litigation Reform Act of 1995. These statements are centered upon our present anticipations and converse only as of the date hereof. Our actual benefits may possibly differ materially and adversely from all those expressed in any forward-wanting statements as a end result of several factors and uncertainties, together with our skill to near on the agreement in a timely fashion, efficiently finish a Stage 1 scientific demo, the economic slowdown influencing companies, our capacity to correctly produce merchandise, immediate modifications in our marketplaces, alterations in desire for our future merchandise, and legislative, regulatory, competitive developments and general financial problems.
Media and Buyers Contacts:
Source: Odyssey Group Intercontinental, Inc.
Check out supply model on accesswire.com: